LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease
Experimental Brain Research · 2026
DOI: 10.1007/s00221-026-07364-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Brain Research, 2026. Verfasst von Di Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Metabolomics, Drugs, Chinese Herbal. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Jilin Provincial Health Commission Health and Technology Capacity Improvement Plan Project, Jilin Provincial Administration of Traditional Chinese Medicine Science and Technology Project.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive impairment of cognition, behavior, and functional abilities that can ultimately lead to death. Cognitive Formula 1 (CF1), a traditional Chinese medicine (TCM) formulation, has demonstrated promising therapeutic efficacy in clinical applications. However, the precise mechanisms underlying its therapeutic effects in AD remain unclear. An AD rat model was established by intracerebral injection of amyloid-β peptide 1-42 (Aβ₁₋₄₂) to investigate the mechanism of CF1. The results indicated that synergistic interactions among multiple CF1 components influence host metabolic pathways, in particular those involved in glycerophospholipid and amino acid metabolism, thereby suggesting an explanation for the alleviation of systemic metabolic dysregulation by the formulation. CF1 also remodeled the gut microbiota by reducing the abundance of potentially detrimental bacteria, such as Veillonella and Lachnoclostridium, while enhancing that of beneficial bacteria, such as Roseburia. These changes improved intestinal homeostasis, reduced endotoxin influx, and alleviated systemic inflammation. The concurrent improvements in host metabolism and gut microbial composition prevented peripheral pro-inflammatory and oxidative stress signals from reaching the brain, thus inhibiting overactivation of hippocampal microglia and attenuating neuroinflammation. These effects preserved neuronal structure and function, ultimately enhancing learning, memory, and spatial cognition in AD model rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China.
- Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China. xiangke1961@163.com.
- Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China. yangzhen9099@163.com.
Förderung
- Jilin Provincial Health Commission Health and Technology Capacity Improvement Plan Project
- Jilin Provincial Administration of Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Wu, D., Lin, Y., Guo, W., Wang, Z., Chang, Y., Yan, J., Han, D., Xiang, K., & Yang, Z. (2026). LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease. Experimental Brain Research. https://doi.org/10.1007/s00221-026-07364-0
Vancouver
Wu D, Lin Y, Guo W, Wang Z, Chang Y, Yan J, et al. LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease. Experimental Brain Research. 2026. doi:10.1007/s00221-026-07364-0
BibTeX
@article{Wu2026,
author = {Wu, Di and Lin, Yanling and Guo, Wenjun and Wang, Zengling and Chang, Yan and Yan, Jing and Han, Daqing and Xiang, Ke and Yang, Zhen},
title = {LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease},
journal = {Experimental Brain Research},
year = {2026},
doi = {10.1007/s00221-026-07364-0}
}
EUVIMED